CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to MIRM

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

1

Regulatory Approvals

Development History
Oct '26
MIRMPhase 3
✓Positive

Maralixibat Phase 3 Est. Readout

Maralixibat
Oct 2026~
CT.gov
Competitive Landscape
Drug Information

Target Indication

Biliary Atresia

Clinical Trial

NCT04524390

Last updated: 12/29/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Regulatory Approvals
EMAPending

Livmarli

Treatment of progressive familial intrahepatic cholestasis type 2 (PFIC2)

Orphan
View on EMA
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.